Home
About
Overview
Sharing Data
ORCID
Help
History (12)
The Agency for Healthcare Research and Quality Inpatient Quality Indicator #11 overall mortality rate does not accurately assess mortality risk after abdominal aortic aneurysm repair.
Cyclic Nucleotide Phosphodiesterases, Type 3
Developing the evidence base for families living with parental psychiatric disabilities: crossing the bridge while we're building it.
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against Neisseria meningitidis and Streptococcus pneumoniae.
Critical issues in gene therapy for neurologic disease.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Critical issues in gene therapy for neurologic disease.
Hsich G, Sena-Esteves M, Breakefield XO. Critical issues in gene therapy for neurologic disease. Hum Gene Ther. 2002 Mar 20; 13(5):579-604.
View in:
PubMed
subject areas
Central Nervous System Diseases
Genetic Therapy
Genetic Vectors
Humans
Risk Factors
authors with profiles
Miguel Sena-Esteves PhD